> Japanese drugmaker Eisai is sending about 60% of its Indian-made APIs by ship while Hospira ($HSP) ships its by air. Report
> Indian API maker SMS Pharmaceuticals said a plant in Vizianagaram in Andhra Pradesh has passed a U.S. FDA inspection. Report
> Small Indian drug companies are weighing the benefits and risks of meeting international manufacturing standards. Story
> The Indian government intends to invest some money in public manufacturing facilities in its effort to help wean the country off foreign-made APIs. Report